Authors: Created 2003; Updated Katrina Tan, Medical Student, Monash University, Melbourne, Australia; Dr Martin Keefe, Dermatologist, Christchurch, New Zealand. Copy edited by Gus Mitchell. June 2021
Tinea cruris, also known as ‘jock itch’, is a specific form of tinea due to a dermatophyte fungus affecting the groin, pubic region, and adjacent thigh. It presents as an acute or chronicasymmetricalrash.
Tinea cruris
Unilateral rash in groin
Raised border and central clearing
Well-definedplaque
Who gets tinea cruris?
Tinea cruris affects both sexes, with a male predominance (3:1). All ages can develop tinea cruris, adolescents and adults more commonly than children and the elderly. Tinea cruris can affect all races, being particularly common in hot humid tropical climates.
Tinea cruris is caused by a dermatophyte fungus, most commonly Trichophyton rubrum and Epidermophyton floccosum.
Spread of the infection to the groin is commonly from the feet (tinea pedis) or nails (tinea unguium) by scratching or use of contaminated towels or bed sheets.
What are the clinical features of tinea cruris?
Tinea cruris usually begins in the inguinal (groin) skin fold on one side which can evolve to become a bilateral but characteristically asymmetrical rash.
The rash can extend down the inner aspect of the thigh or to the lower abdomen and pubic area.
Involvement of the buttocks and perineum may be seen but there is typically sparing of the penis, scrotum, and vulva.
Acute tinea cruris may present as a moist and exudative rash.
Chronic tinea cruris presents as a large well-demarcatedscaly plaque with a raised border and central clearing.
Scale is most prominent at the leading edge of the plaque.
Dermatophytic folliculitis may present as papules and pustules along the border.
Tinea cruris should be considered in the clinical setting of an asymmetrical scaly rash in the groin and confirmed on a skin scraping for mycology [see Laboratory tests for fungal infections].
Oral antifungal medication for extensive or recalcitrant infection, particularly in immunosuppressed patients eg, griseofulvin, terbinafine, itraconazole
Treatment of tinea at other sites such as tinea pedis or tinea unguium
Mild topical steroid can be used short-term to reduce itch, but is not appropriate as a monotherapy or long-term
What is the outcome for tinea cruris?
Tinea cruris clears with appropriate treatment in 80–90% of cases. However, recurrence is common, especially if predisposing factors are not addressed or antifungal treatment is stopped before mycological cure. Residual hyperpigmentation may persist in skin of colour.
Bibliography
Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician. 2008;77(10):1415–20. Journal
Bhat YJ, Keen A, Hassan I, Latif I, Bashir S. Can dermoscopy serve as a diagnostic tool in dermatophytosis? A pilot study. Indian Dermatol Online J. 2019;10(5):530–5. doi:10.4103/idoj.IDOJ_423_18. Journal
Bhatia A, Kanish B, Badyal DK, Kate P, Choudhary S. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin - a prospective, randomized comparative study. Indian J Pharmacol. 2019;51(2):116-19. doi:10.4103/ijp.IJP_578_17. Journal
El-Gohary M, van Zuuren EJ, Fedorowicz Z, et al. Topical antifungal treatments for tinea cruris and tinea corporis. Cochrane Database Syst Rev. 2014;(8):CD009992. doi:10.1002/14651858.CD009992.pub2. Journal
Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702–10. Journal
Patel GA, Wiederkehr M, Schwartz RA. Tinea cruris in children. Cutis. 2009;84(3):133–7. PubMed
Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J. 2016;7(2):77–86. doi:10.4103/2229-5178.178099. Journal
Zhao D, Chen B, Wang YT, Jiao CH. Topical clotrimazole cream for the treatment of tinea cruris: a retrospective study. Medicine (Baltimore). 2020;99(47):e23189. doi:10.1097/MD.0000000000023189. Journal